Synthesis of acrylamide-g-melanin/itaconic acid-g-psyllium based nanocarrier for capecitabine delivery: In vivo and in vitro anticancer activity

Abstract

The present research aims to synthesize the capecitabine-loaded core–shell nanoparticles of acrylamide-grafted melanin and itaconic acid-grafted psyllium (Cap@AAM-g-ML/IA-g-Psy-NPs) to deliver the drug to the targeted colonic area, enhancing their anti-cancer activity. The drug release behavior of Cap@AAM-g-ML/IA-g-Psy-NPs was studied at several biological pH in which maximum drug release (95 %) was observed at pH 7.2. The drug release kinetic data was in accordance with the first-order (R2 = 0.9706) kinetic model. The cytotoxicity of Cap@AAM-g-ML/IA-g-Psy-NPs was investigated on HCT-15 cell line and Cap@AAM-g-ML/IA-g-Psy-NPs demonstrated outstanding toxicity towards HCT-15 cell line. In-vivo study on DMH-induced colon cancer rat model also exhibited that Cap@AAM-g-ML/IA-g-Psy-NPs enhanced anticancer activity against cancer cells as compared to capecitabine. Histology studies of heart, liver and kidney cells indicate that inflation due to cancer induction by DMH is significantly reduced when treated with Cap@AAM-g-ML/IA-g-Psy-NPs. Thus, the present study procures a worthwhile and nominal approach toward the synthesis of Cap@AAM-g-ML/IA-g-Psy-NPs for anticancer applications.